June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
In vitro in vivo correlation of dexamethasone TIPS particles
Author Affiliations & Notes
  • Sahar Awwad
    UCL, The School of Pharmacy, London, United Kingdom
    National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom
  • Richard M. Day
    UCL Division of Medicine, London, United Kingdom
  • Peng Tee Khaw
    National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom
  • Hala Fadda
    Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Butler University, Indianapolis, Indiana, United States
  • Steve Brocchini
    UCL, The School of Pharmacy, London, United Kingdom
    National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom
  • Footnotes
    Commercial Relationships   Sahar Awwad, None; Richard M. Day, None; Peng Khaw, None; Hala Fadda, None; Steve Brocchini, None
  • Footnotes
    Support  National Institute of Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, Moorfields Special Trustees, the Helen Hamlyn Trust (in memory of Paul Hamlyn), Medical Research Council, Fight for Sight and the Michael and Ilse Katz foundation; UCL Overseas Research Student Fund and UCL Comprehensive Biomedical Research Centre. The research was also undertaken at UCL/UCLH which receives funding from the Department of Health’s NIHR as a Comprehensive Biomedical Research Centre.
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 4452. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Sahar Awwad, Richard M. Day, Peng Tee Khaw, Hala Fadda, Steve Brocchini; In vitro in vivo correlation of dexamethasone TIPS particles. Invest. Ophthalmol. Vis. Sci. 2017;58(8):4452.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Corticosteroids are often administered to the posterior segment of the eye via intravitreal (IVT) injections. However, due to their short half-life (t1/2) of 3-7 hours, repeated injections are necessary to maintain a therapeutic dose over intermediate time periods (e.g. 1-2 weeks). There has been much effort to extend the ocular residence time of steroids and other drugs by formulating them into polymeric implants and devices to achieve a prolonged and sustained release profile. We have designed dexamethasone poly-DL-lactide-co-glycolide (PLGA) microparticles to provide sustained release after IVT administration and to predict their in vivo t1/2 using an in vitro ocular dissolution model (PK-Eye).

Methods : Dexamethasone-loaded (0.2 mg) PLGA microparticles were fabricated using a thermally induced phase separation (TIPS) and lyophilisation method. The release profile of the TIPS microparticles was evaluated using the proprietary PK-Eye, a two-compartment model that simulates aqueous outflow to estimate drug clearance time from the ocular posterior cavity. Drug release was investigated in both PBS with pH 7.4 and simulated vitreous, which mimic vitrectomised and non-vitrectomised eyes respectively.

Results : Dexamethasone TIPS microparticles were successfully developed and shown to provide sustained in vitro drug release. The particles showed an in vitro t1/2 of 1.0 ± 0.1 days in PBS and 9.6 ± 0.3 days in simulated vitreous. In vivo t1/2 was then predicted using in vitro drug release and retinal permeability data. Predicted in vivo t1/2 was determined to be 48 hours, almost 9 times longer than that reported for dexamethasone suspension. This approach was validated with in vitro drug profiles and published in vivo data for triamcinolone acetonide and dexamethasone suspensions. In vitro in vivo correlations (IVIVC) for intraocular clearance times were successfully achieved using this approach.

Conclusions : Dexamethasone-PLGA TIPS microparticles provide sustained drug delivery of intermediate duration which is useful for acute ocular conditions of the posterior segment. Integrating drug permeation across the retinal choroid sclera (RCS) pathway with anterior aqueous outflow from the PK-Eye allows the in vivo drug clearance of suspensions and implants from the vitreous compartment to be predicted.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×